Mixing versus matching booster vaccines: Longitudinal humoral immune kinetics against Omicron in a Malaysian cohort
Authors:
- Ashwathy Varadarajan ThundakattilATAshwathy Varadarajan Thundakattil
- Rekha PrabhuRPRekha Prabhu
- Girish PrabhuGPGirish Prabhu
- Muthuvel ManiMMMuthuvel Mani
- Somsubhra DeSDSomsubhra De
- Htoo Htoo Kyaw SoeHSHtoo Htoo Kyaw Soe
- Charlotte Patrick ArjunanCACharlotte Patrick Arjunan
- Sumandeep Kaur ChahlSCSumandeep Kaur Chahl
- Debban A/L RameshDRDebban A/L Ramesh
- Ng Jian ChenNCNg Jian Chen
- Soh Pei QiSQSoh Pei Qi
- Jaayshree A/P PrakashJPJaayshree A/P Prakash
Open Access
- 4 September 2026
- journal article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 172
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S)Vaccine, 2025
- Homologous and Heterologous Covid-19 Booster Vaccinations Against SARS-CoV-2 Infection in the ElderlyCurrent Microbiology, 2024
- Long-term immunogenicity in previously vaccinated healthcare workers with inactivated virus vaccine after SARS-CoV-2 infection or booster vaccinationVaccine: X, 2023
- Omicron (BA.1) and sub‐variants (BA.1.1, BA.2, and BA.3) of SARS‐CoV‐2 spike infectivity and pathogenicity: A comparative sequence and structural‐based computational assessmentJournal of Medical Virology, 2022
- Characterization of the significant decline in humoral immune response six months post‐SARS‐CoV‐2 mRNA vaccination: A systematic reviewJournal of Medical Virology, 2022
- Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong KongEBioMedicine, 2022
- mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variantCell, 2022
- Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trialThe Lancet, 2021
- Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platformThe Lancet, 2021
- Sex differences in immune responsesNature Reviews Immunology, 2016